Palmoplantar Pustulosis-like Eruption Induced by Baricitinib for Treatment of Rheumatoid Arthritis

Objectives: Baricitinib is an orally active Janus kinase (JAK) inhibitor used in the treatment of moderate to severe rheumatoid arthritis (RA). Materials and methods: Here, we report the case of a 56-year-old Caucasian male diagnosed with RA who developed palmoplantar pustulosis (PPP) while being t...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Prif Awduron: Dimitra Koumaki, Vasiliki Koumaki, George Bertsias, Eleni Lagoudaki
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: SMC MEDIA SRL 2019-12-01
Cyfres:European Journal of Case Reports in Internal Medicine
Pynciau:
palmoplantar pustulosis
baricitinib
rheumatoid arthritis
cutaneous side effects
Mynediad Ar-lein:https://www.ejcrim.com/index.php/EJCRIM/article/view/1383
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg